The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
MicroRNAs 103 and 107 regulate insulin sensitivity
Open accessAbstract
Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MicroRNA inhibitors (antagomirs) targeting miR-103 and miR-107 improve insulin sensitivity and reduce adiposity in diet-induced obese mice by enhancing hepatic and peripheral insulin signaling [92].”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citationCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,456
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 996
Zaki, M. B., Abulsoud, A. I., Elsisi, A. M., Doghish, A. S., Mansour, O. A., Amin, A. I., Elrebehy, M. A., Mohamed, M. Y., & Goda, M. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s187422 · Cited by 78
Anaparti, V., Smolik, I., Meng, X., Spicer, V., Mookherjee, N., & El-Gabalawy, H. S. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1459-x · Cited by 81
miRNAs as cornerstones in adipogenesis and obesity
Elkhawaga, S. Y., Ismail, A., Elsakka, E. G. E., Doghish, A. S., Elkady, M. A., & El‐Mahdy, H. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121382 · Cited by 78
Briand, N., Prado, C., Mabilleau, G., Lasnier, F., Lièpvre, X. L., Covington, J. D., Ravussin, É., Lay, S. L., & Dugail, I. (2014) · Diabetes · doi:10.2337/db13-1961 · Cited by 77
Odle, A. K., Akhter, N., Syed, M., Allensworth‐James, M. L., Beneš, H., Castillo, A. I. M., MacNicol, M. C., MacNicol, A. M., & Childs, G. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00367 · Cited by 81
Yaribeygi, H., Katsiki, N., Behnam, B., Iranpanah, H., & Sahebkar, A. (2018) · Metabolism · doi:10.1016/j.metabol.2018.07.001 · Cited by 74
Kaur, K., Vig, S., Srivastava, R., Mishra, A., Singh, V. P., Srivastava, R., & Datta, M. (2015) · Diabetes · doi:10.2337/db14-1924 · Cited by 75
Xiao, J., Bei, Y., Liu, J., Dimitrova‐Shumkovska, J., Kuang, D., Zhou, Q., Li, J., Yang, Y., Xiang, Y., Wang, F., et al. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12733 · Cited by 75
Micro RNA s: the fine modulators of liver development and function
Chen, Y., & Verfaillie, C. M. (2014) · Liver International · doi:10.1111/liv.12496 · Cited by 74
Human CYP2C8 Is Post-Transcriptionally Regulated by MicroRNAs 103 and 107 in Human Liver
Zhang, S., Surapureddi, S., Coulter, S. J., Ferguson, S., & Goldstein, J. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078386 · Cited by 74
Cavalleri, T., Angelici, L., Favero, C., Dioni, L., Mensi, C., Bareggi, C., Palleschi, A., Rimessi, A., Consonni, D., Bordini, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176680 · Cited by 74
Nteeba, J., Ortinau, L. C., Perfield, J. W., & Keating, A. F. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22231 · Cited by 74
Otsuka, M., Kishikawa, T., Yoshikawa, T., Yamagami, M., Ohno, M., Takata, A., Shibata, C., Ishibashi, R., & Koike, K. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.53 · Cited by 73
The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP
Hamilton, M. P., Rajapakshe, K., Bader, D. A., Cerne, J. Z., Smith, E. A., Coarfa, C., Hartig, S. M., & McGuire, S. E. (2016) · Neoplasia · doi:10.1016/j.neo.2016.04.008 · Cited by 71
MiR‐103‐3p targets the m6A methyltransferase METTL14 to inhibit osteoblastic bone formation
Sun, Z., Wang, H., Wang, Y., Yuan, G., Yu, X., Jiang, H., Wu, Q., Yang, B., Hu, Z., Shi, F., et al. (2021) · Aging Cell · doi:10.1111/acel.13298 · Cited by 73
Time-Dependent Expression Profiles of microRNAs and mRNAs in Rat Milk Whey
Izumi, H., Kosaka, N., Shimizu, T., Sekine, K., Ochiya, T., & Takase, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088843 · Cited by 73
Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus
Sommese, L., Zullo, A., Mancini, F. P., Fabbricini, R., Soricelli, A., & Claudio Napoli, A. (2017) · Epigenetics · doi:10.1080/15592294.2016.1278097 · Cited by 73
Herradón, G., Ramos, P., & Gramage, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00377 · Cited by 73
Epigenetic effects of ethanol on the liver and gastrointestinal system
Shukla, S. D. (2013) · Alcohol research · doi:10.35946/arcr.v35.1.06 · Cited by 71
Wagner, V., Kern, F., Hahn, O., Schaum, N., Ludwig, N., Fehlmann, T., Engel, A., Henn, D., Rishik, S., Isakova, A., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01751-6 · Cited by 72
miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1
Zhang, Y., Qu, X., Li, C., Fan, Y., Che, X., Wang, X., Cai, Y., Hu, X., & Liu, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-2835-7 · Cited by 69
MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN
Li, G., Sun, B., Gao, B., Wang, Z., Quan, C., Feng, W., & Fang, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058458 · Cited by 69
Sun, W., Yang, J., Wang, W., Hou, J., Cheng, Y., Fu, Y., Xu, Z., & Cai, L. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.12.005 · Cited by 68
Chronic Ethanol Feeding Alters mi RNA Expression Dynamics During Liver Regeneration
Dippold, R. P., Vadigepalli, R., Gonye, G. E., Patra, B., & Hoek, J. B. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01852.x · Cited by 68
Assmann, T. S., Recamonde‐Mendoza, M., Puñales, M. K., Tschiedel, B., Canani, L. H. S., & Crispim, D. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.044 · Cited by 67
MicroRNAs: a new ray of hope for diabetes mellitus
Kumar, M., Nath, S., Prasad, H. K., Sharma, G., & Li, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2055-0 · Cited by 66
NOX4 Pathway as a Source of Selective Insulin Resistance and Responsiveness
Wu, X., & Williams, K. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244525 · Cited by 67
Chen, Y., Zubović, L., Yang, F., Godin, K. S., Pavelitz, T., Castellanos, J., Macchi, P., & Varani, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw177 · Cited by 66
miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy
Badal, S. S., Wang, Y., Long, J., Corcoran, D. L., Chang, B. H., Truong, L. D., Kanwar, Y. S., Overbeek, P. A., & Danesh, F. R. (2016) · Nature Communications · doi:10.1038/ncomms12076 · Cited by 67
Zhuo, S., Yang, M., Zhao, Y., Chen, X., Zhang, F., Li, N., Yao, P., Zhu, T., Mei, H., Wang, S., et al. (2016) · Diabetes · doi:10.2337/db16-0166 · Cited by 67
miR-107 regulates tumor progression by targeting NF1 in gastric cancer
Wang, S., Ma, G., Zhu, H., Lv, C., Chu, H., Tong, N., Wu, D., Qiang, F., Gong, W., Zhao, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep36531 · Cited by 67
Tang, K. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117011 · Cited by 72
Lin, X., Luo, J., Zhang, L., & Zhu, J. (2013) · Gene Expression · doi:10.3727/105221613x13776146743262 · Cited by 66
Zhu, X., Liu, H., Zhang, Z., Wei, R., Zhou, X., Wang, Z., Zhao, L., Guo, Q., Zhang, Y., Chu, C., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46144 · Cited by 66
Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics
Batabyal, R., Freishtat, N., Hill, E., Rehman, M., Freishtat, R. J., & Koutroulis, I. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00804-7 · Cited by 69
McGregor, R. A., Poppitt, S. D., & Cameron‐Smith, D. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.05.001 · Cited by 66
Traver, S., Assou, S., Scalici, E., Haouzi, D., Al-Edani, T., Belloc, S., & Hamamah, S. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu031 · Cited by 67
microRNAs as Regulators of Adipogenic Differentiation of Mesenchymal Stem Cells
Hamam, D., Ali, D., Kassem, M., Aldahmash, A., & Alajez, N. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0331 · Cited by 67
Vinciguerra, A., Formisano, L., Cerullo, P., Guida, N., Cuomo, O., Esposito, A., Renzo, G. D., Annunziato, L., & Pignataro, G. (2014) · Molecular Therapy · doi:10.1038/mt.2014.113 · Cited by 67
Non-coding RNAs and Berberine: A new mechanism of its anti-diabetic activities
Chang, W. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.055 · Cited by 66
Caveolin‐1 deficiency induces premature senescence with mitochondrial dysfunction
Yu, D., Jung, S. H., An, H., Lee, S., Hong, J. H., Park, J. S., Lee, H., Lee, H., Bahn, M., Lee, H. C., et al. (2017) · Aging Cell · doi:10.1111/acel.12606 · Cited by 69
Kaur, P., Kotru, S., Singh, S., Behera, B. S., & Munshi, A. (2020) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00760-2 · Cited by 69
MicroRNAs in diabetes and diabetes-associated complications
Lorenzen, J. M., Kumarswamy, R., Dangwal, S., & Thum, T. (2012) · RNA Biology · doi:10.4161/rna.20162 · Cited by 68
MicroRNA networks regulate development of brown adipocytes
Trajkovski, M., & Lodish, H. F. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.05.002 · Cited by 70
Self-citationHigh fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression
Nteeba, J., Ross, J. W., Perfield, J. W., & Keating, A. F. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.07.026 · Cited by 66
Cell-Specific Dysregulation of MicroRNA Expression in Obese White Adipose Tissue
Oger, F., Gheeraert, C., Mogilenko, D. A., Benomar, Y., Molendi‐Coste, O., Bouchaert, E., Caron, S., Dombrowicz, D., Pattou, F. N., Duez, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4259 · Cited by 67
Kemper, J. K., Choi, S.-E., & Kim, D.-H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00016-x · Cited by 65
miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease
Xu, Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.511 · Cited by 63
Diverse Functions of Endothelial NO Synthases System
Shimokawa, H., & Godo, S. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000348 · Cited by 64
Epigenetics and Cellular Metabolism
Xu, W., Wang, F., Yu, Z., & Xin, F. (2016) · Genetics & Epigenetics · doi:10.4137/geg.s32160 · Cited by 68
The role of miRNAs in cardiovascular disease risk factors
Buie, J. N. J., Goodwin, A. J., IV, Cook, J. A., Halushka, P. V., & Fan, H. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.067 · Cited by 63
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
Wilson, R., Espinosa‐Díez, C., Kanner, N., Chatterjee, N., Ruhl, R. A., Hipfinger, C., Advani, S. J., Li, J., Khan, O. F., Franovic, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13597 · Cited by 63
Vaishya, S., Sarwade, R. D., & Seshadri, V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00180 · Cited by 67
Timescales and bottlenecks in miRNA‐dependent gene regulation
Hausser, J., Syed, A. P., Selevsek, N., van Nimwegen, E., Jaśkiewicz, Ł., Aebersold, R. H., & Zavolan, M. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.68 · Cited by 61
Self-citationMicroRNAs in Bone Balance and Osteoporosis
Chen, J., Qiu, M. R., Dou, C., Cao, Z., & Dong, S. (2015) · Drug Development Research · doi:10.1002/ddr.21260 · Cited by 62
mi RNA s, polyphenols, and chronic disease
Bladé, C., Baselga‐Escudero, L., Salvadó, M. J., & Arola‐Arnal, A. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200454 · Cited by 64
Key principles of miRNA involvement in human diseases
Giza, D. E., Vasilescu, C., & Calin, G. A. (2014) · Discoveries · doi:10.15190/d.2014.26 · Cited by 64
Noncoding RNAs and pancreatic cancer
Peng, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.801 · Cited by 65
Yang, W., Min, K.-H., & Lee, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0169039 · Cited by 62
Chen, Y., Chiu, C.-C., Hung, S., Huang, W.-C., Lee, Y.-P., Liu, J.-Y., Huang, Y.-T., Chen, T.-H., & Chuang, H.-L. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.07.001 · Cited by 60
Romão, J. M., Jin, W., He, M., McAllister, T. A., & Guan, L. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040605 · Cited by 60
microRNA-103/107 Family Regulates Multiple Epithelial Stem Cell Characteristics
Peng, H., Park, J. K., Katsnelson, J., Kaplan, N., Yang, W., Getsios, S., & Lavker, R. M. (2015) · Stem Cells · doi:10.1002/stem.1962 · Cited by 61
Strategies to use microRNAs as therapeutic targets
Krützfeldt, J. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.07.004 · Cited by 62
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Rech, M., Aizpurua, A. B., van Empel, V. P. M., van Bilsen, M., & Schroen, B. L. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy049 · Cited by 61
Beuzelin, D., & Kaeffer, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02711 · Cited by 61
Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity
Cruz, K. J. C., de Oliveira, A. R. S., Morais, J. B. S., Severo, J. S., & Marreiro, D. D. N. (2016) · Nutrition · doi:10.1016/j.nut.2016.10.003 · Cited by 60
Epigenetic contribution to obesity
Ouni, M., & Schürmann, A. (2020) · Mammalian Genome · doi:10.1007/s00335-020-09835-3 · Cited by 68
Oxidative-stress-induced epigenetic changes in chronic diabetic complications
Feng, B., Ruiz, M. A., & Chakrabarti, S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0251 · Cited by 59
Gottmann, P., Ouni, M., Saussenthaler, S., Roos, J., Stirm, L., Jähnert, M., Kamitz, A., Hallahan, N., Jonas, W., Fritsche, A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.005 · Cited by 59
Klieser, E., Mayr, C., Kiesslich, T., Wissniowski, T., Fazio, P. D., Neureiter, D., & Ocker, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215266 · Cited by 59
Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system
Daimiel, L., Klett‐Mingo, M., Konstantinidou, V., Micó, V., Aranda, J. F., García, B., Martı́nez-Botas, J., Dávalos, A., Fernandez-Hernando, C. F., & Ordovás, J. M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400616 · Cited by 58
Song, H., Luo, Y., Li, D., Wei, C., Hua, K., Song, J., Xu, H., Maskey, N., & Fang, L. (2015) · PubMed Central · Cited by 58
Li, K., Wei, P., Qin, Y., & Wei, Y. (2017) · Medicine · doi:10.1097/md.0000000000007917 · Cited by 60
Xiong, J., Wang, D., Wei, A., Lü, H., Tan, C., Li, A., Tang, J., Wang, Y., He, S., Liu, X., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.10.033 · Cited by 58
Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
Heo, M. J., Yun, J., & Kim, S. G. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-018-01104-x · Cited by 57
miR-142 controls metabolic reprogramming that regulates dendritic cell activation
Sun, Y., Oravecz-Wilson, K. I., Bridges, S., McEachin, R. C., Wu, J. J., Kim, S. H., Taylor, A., Zajac, C. K., Fujiwara, H., Peltier, D., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123839 · Cited by 58
Yao, Z., Chen, W., Shao, S., Ma, S., Yang, C., Li, M.-Z., Zhao, J., & Gao, L. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600490 · Cited by 57
RNA-Binding Protein PTB and MicroRNA-221 Coregulate AdipoR1 Translation and Adiponectin Signaling
Lustig, Y., Barhod, E., Ashwal-Fluss, R., Gordin, R., Shomron, N., Umansky, K. B., Hemi, R., Karasik, A., & Kanety, H. (2013) · Diabetes · doi:10.2337/db13-1032 · Cited by 56
microRNA profiling in atherosclerosis, diabetes, and migraine
Tana, C., Giamberardino, M. A., & Cipollone, F. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1226515 · Cited by 58
Wang, D., Hu, X., Lee, S. H., Chen, F., Jiang, K., Tu, Z., Liu, Z., Du, J., Wang, L., Yin, C., et al. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.01.005 · Cited by 59
Yang, X., Niu, X., Xiao, Y., Lin, K., & Chen, X. (2018) · Respiratory Research · doi:10.1186/s12931-018-0894-9 · Cited by 57
miR-145 improves metabolic inflammatory disease through multiple pathways
He, M., Wu, N., LEONG, M., Zhang, W., Ye, Z., Li, R., Huang, J.-Y., Zhang, Z., Li, L., Xiao, Y., et al. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz015 · Cited by 59
Deciphering Non-coding RNAs in Cardiovascular Health and Disease
Das, A., Samidurai, A., & Salloum, F. N. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00073 · Cited by 56
microRNAs in Human Adipose Tissue Physiology and Dysfunction
Kuryłowicz, A. (2021) · Cells · doi:10.3390/cells10123342 · Cited by 60
Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease
Albinsson, S., & Swärd, K. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.003 · Cited by 56
Bhatia, H., Verma, G., & Datta, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.02.009 · Cited by 56
Auguet, T., Aragonès, G., Berlanga, A., Guiu‐Jurado, E., Martí, A., Martínez, S., Sabench, F., Hernández, M., Aguilar, C., Sirvent, J. J., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101620 · Cited by 56
The interplay between noncoding RNAs and insulin in diabetes
Tian, Y., Xu, J. M., Du, X., & Fu, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.038 · Cited by 57
RNA therapeutics: Identification of novel targets leading to drug discovery
Qadir, M. I., Bukhat, S., Rasul, S., Manzoor, H., & Manzoor, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29364 · Cited by 57
Mennigen, J. A., Cassy, S., & Panserat, S. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.082248 · Cited by 55
Relevance of microRNA in metabolic diseases
Price, N. L., Ramírez, C. M., & Fernandez-Hernando, C. F. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.937522 · Cited by 55
Lie, S., Morrison, J. L., Williams-Wyss, O., Suter, C. M., Humphreys, D. T., Ozanne, S. E., Zhang, S., MacLaughlin, S. M., Kleemann, D. O., Walker, S. K., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00553.2013 · Cited by 55
Lehrbach, N. J., Castro, C., Murfitt, K. J., Abreu‐Goodger, C., Griffin, J. L., & Miska, E. A. (2012) · RNA · doi:10.1261/rna.035402.112 · Cited by 56
Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
Tian, Y., Mok, M. T. S., Yang, P., & Cheng, A. S. L. (2016) · Cancers · doi:10.3390/cancers8080076 · Cited by 55
MicroRNAs and metabolic disorders – where are we heading?
Śliwińska, A., Kasińska, M., & Drzewoski, J. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65229 · Cited by 55
Barrier Function of the Repaired Skin Is Disrupted Following Arrest of Dicer in Keratinocytes
Ghatak, S., Chan, Y. C., Khanna, S., Banerjee, J., Weist, J., Roy, S., & Sen, C. K. (2015) · Molecular Therapy · doi:10.1038/mt.2015.65 · Cited by 54
Lay, S. L., & Scherer, P. E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115732 · Cited by 62
Afzal, T. A., Luong, L. A., Chen, D., Zhang, C., Yang, F., Chen, Q., An, W., Wilkes, E. H., Yashiro, K., Cutillas, P. R., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004629 · Cited by 54
Polymer nanocarriers for MicroRNA delivery
Kapadia, C. H., Luo, B., Dang, M. N., Irvin-Choy, N. S., Valcourt, D. M., & Day, E. S. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.48651 · Cited by 60
Hromadníková, I., Kotlabová, K., Dvořáková, L., & Krofta, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072437 · Cited by 54
Metadata
- Authors
- Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- University of Basel (CH)
- Regulus Therapeutics (United States) (US)
- University Hospital of Basel (CH)
- Corresponding author
- Stoffel, Markus
- Venue
- Nature
- Published
- 2011-06
- Volume
- 474
- Issue
- 7353
- Pages
- 649-653
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075317528
- Cited by
- 1,000
- References
- 27
- Citations by year
- 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Juvenile Diabetes Research Foundation International
- Fondation Leducq
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review